
Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy
WASHINGTON — Shares of drugmaker Sarepta Therapeutics continued to fall Tuesday after the company said it would comply with a Food and Drug Administration request to pause shipments of its gene therapy following several patient deaths.
The decision, announced late Monday, comes just days after the company rebuffed FDA regulators in an extremely unusual decision that alarmed investors and analysts.
Sarepta CEO Doug Ingram said the company seeks a 'productive and positive' relationship with FDA and that 'maintaining that productive working relationship required this temporary suspension.'
The Cambridge, Massachusetts-based company said it would ' temporarily pause all shipments' of its gene therapy Elevidys for muscular dystrophy at the close of business Tuesday.
It's the latest in a series of highly irregular moves that have rocked company shares for weeks and forced it to lay off hundreds of staffers.
Elevidys is the first gene therapy approved in the U.S. for Duchenne's muscular dystrophy, the fatal muscle-wasting disease that affects boys and young men, resulting in early death. The one-time treatment was initially approved for boys age 4 and younger who could still walk. Last year, FDA expanded approval to older patients who are no longer able to walk.
The therapy was already under FDA scrutiny after two teenage boys died earlier this year from acute liver injury, a known side effect of the treatment. Then the company last week disclosed a third death with a different therapy: a 51-year-old patient who was enrolled in a company trial for a another form of muscular dystrophy.
FDA responded by asking the company to immediately halt all shipments of Elevidys.
Wall Street analysts said the company made the right move.
Defying the FDA would have 'irreparably damaged the company's relationship with FDA under the current leadership and administration,' TD Cowen analyst Ritu Baral told investors in a note Tuesday.
Baral estimated the pause in distribution would last three to six months.
The FDA has the authority to pull drugs from the market, but the process can take months or even years. Instead, the agency usually makes an informal request and companies almost always comply. Even in the rare cases when drugmakers haven't cooperated, the FDA has prevailed after public hearings and appeals.
___
Matthew Perrone, The Associated Press
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
16 hours ago
- Globe and Mail
Manhattan Laser Spa Continues to Set the Standard for Non-Invasive Aesthetic Care in Sunny Isles Beach
Manhattan Laser Spa expands in Sunny Isles Beach, offering expert laser hair removal, Botox, and dermal fillers under Mila Alishaev's leadership. Sunny Isles Beach, FL - July 24, 2025 - Manhattan Laser Spa, led by Founder and CEO Mila Alishaev, is proud to reaffirm its commitment to cutting-edge, non-invasive aesthetic solutions at its Sunny Isles Beach location. With a growing reputation for excellence, the spa continues to offer clients in South Florida personalized, high-quality treatments that prioritize safety, innovation, and natural-looking results. At the heart of this continued success is a focus on clinical expertise, modern technology, and a personalized approach to beauty. Alishaev, a seasoned entrepreneur and visionary in the cosmetic industry, emphasizes that every service offered at Manhattan Laser Spa is guided by a singular goal: helping clients look and feel their best without compromising on safety or comfort. Expanding Access to Leading Services in Cosmetic Enhancement With increasing demand for non-surgical beauty procedures, Manhattan Laser Spa has become a trusted name in South Florida. Its Sunny Isles Beach facility offers a full suite of advanced treatments, including laser hair removal, designed to provide long-lasting results with minimal discomfort. This location also specializes in FDA-approved injectables like Botox, a solution widely used to minimize the appearance of fine lines and wrinkles. For those seeking more volume or facial contouring, the spa provides expertly administered dermal fillers, customized to complement individual facial structure and aesthetic goals. These services are performed under the supervision of trained professionals using state-of-the-art equipment, ensuring that every treatment meets the highest standard of care. Alishaev notes, 'Our goal is to make the most trusted aesthetic services accessible to clients in South Florida, while maintaining a strong commitment to medical integrity and visible results.' A Vision Driven by Excellence and Innovation Mila Alishaev's leadership is central to the spa's continued success and expansion. Her passion for innovation and dedication to her clients' satisfaction has not only elevated the spa's reputation but has also helped set a new standard in the aesthetic care industry. By consistently investing in the latest technologies and staff training, she ensures Manhattan Laser Spa remains at the forefront of the cosmetic field. 'Cosmetic enhancements are no longer just about trends; they're about confidence, health, and the power of choice,' says Alishaev. 'At Manhattan Laser Spa, we don't believe in one-size-fits-all. Every client deserves a customized approach based on their individual goals and skin profile.' As the beauty industry evolves, Manhattan Laser Spa remains a leading example of what modern, client-focused care should look like. With its expanded offerings in Sunny Isles Beach and continued dedication to safety and innovation, the spa is positioned to remain a leader in aesthetic medicine for years to come. About Manhattan Laser Spa Founded by Mila Alishaev, Manhattan Laser Spa is a full-service medical spa specializing in non-invasive beauty solutions. With multiple locations, including its growing presence in Sunny Isles Beach, the spa has earned a strong reputation for quality care and natural results. Services include laser hair removal, Botox, dermal fillers, skin rejuvenation, and more. For more information or to schedule a consultation, visit Media Contact Company Name: Manhattan Laser Spa Contact Person: Mila Alishaev Email: Send Email Phone: 7867514733 Address: 16850, Collins Ave #105 City: Sunny Isles Beach State: Florida, 33160 Country: United States Website:


Globe and Mail
16 hours ago
- Globe and Mail
ScalaHosting To Power California State University, Sacramento With Secure, Scalable, and High-Performance Cloud Infrastructure in New Partnership
ScalaHosting's secure, scalable cloud hosting solutions will be integrated into CSUS's digital services to strengthen campus cybersecurity and infrastructure reliability. This new alliance will accelerate digital transformation in higher education. ScalaHosting, a global leader in managed cloud VPS hosting solutions, is proud to announce a multifaceted strategic partnership with California State University, Sacramento (Sac State), one of the largest public universities in California and a recognized leader in academic excellence and innovation. Through this alliance, ScalaHosting will integrate its scalable, secure cloud hosting solutions across CSUS's digital services ecosystem to strengthen its cybersecurity and enhance the performance and reliability of its infrastructure. With growing demand for educational institutions to provide always-on access to online platforms, CSUS is demonstrating its forward-thinking approach to digital infrastructure through this partnership. As one of the most respected institutions in the California State University system, the university plays a pivotal role in shaping the academic and digital experiences of thousands of learners each year. This decision to move to ScalaHosting marks a significant milestone, reinforcing the institution's dedication to delivering web hosting solutions that meet the high standards and expectations of enterprise-level organizations and public institutions. At the same time, this move underscores the university's commitment to security, performance, and long-term scalability as it supports its thousands of students, faculty, and staff. ScalaHosting brings to this partnership its enterprise-grade reliability, ironclad security, lighting fast servers, 24/7 support, and managed VPS cloud hosting. The cloud solutions provider also offers access to cutting-edge tools like Spanel, a control panel designed to reduce complexity and boost control, enabling institutions to streamline their server management without sacrificing flexibility or compliance. In accordance with the partnership, CSUS has initiated the migration of its key websites, including its Moodle LMS websites, to ScalaHosting's cutting-edge Cloud VPS platform. Chris Rusev, the CEO and co-founder of ScalaHosting and expressed his excitement about this partnership, calling it an opportunity for ScalaHosting to flex its cloud hosting and management capabilities and demonstrate how educational institutions can future-proof their digital transformation with next-generation hosting solutions. 'We are excited and honored to support CSUS in its mission to provide secure, scalable, and high-availability services for its learners, staff and faculty. CSUS's trust in us reaffirms our ability to accelerate digital transformation for higher learning by helping institutions manage their key digital resources that support course delivery and academic operations.' This strategic partnership also highlights ScalaHosting's commitment to delivering high-performance hosting environments tailored to various sectors, including education, government, and enterprise. California State University, Sacramento, joins a growing list of organizations turning to ScalaHosting to upgrade their cybersecurity and digital infrastructure with managed cloud hosting. About ScalaHosting: ScalaHosting is a U.S.-based cloud solutions provider trusted by over 1,000,000 websites worldwide. With a focus on innovation, security, and service, ScalaHosting offers fully managed cloud VPS, dedicated servers, and cutting-edge tools like SPanel, the next-generation web hosting control panel. For more information, please visit Media Contact Company Name: ScalaHosting Contact Person: Chris Rusev Email: Send Email Phone: 214 306 6818 Country: United States Website:


Globe and Mail
16 hours ago
- Globe and Mail
Offerpad Solutions Inc. Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement
Offerpad Solutions Inc. ("Offerpad") (NYSE: OPAD), a leading tech-enabled platform for residential real estate, today announced that it has entered into a securities purchase agreement with a single institutional investor for the purchase and sale of 2,857,143 shares of its common stock (or common stock equivalents in lieu thereof) in a registered direct offering at a purchase price of $2.10 per share ('the Registered Offering'). In a concurrent private placement (the "Private Placement" and together with the Registered Offering, the "Offerings"), the Company also agreed to issue to the same investor warrants to purchase up to 1,428,571 shares of its common stock (the "Common Warrants"). The Common Warrants have an exercise price of $2.30 per share, will be exercisable commencing six months from the date of issuance, and will expire four years following the initial exercise date. The closing of the Offerings are expected to occur on or about July 25, 2025, subject to the satisfaction of customary closing conditions. The gross proceeds from the Offerings are expected to be approximately $6 million, before deducting placement agent fees and other estimated offering expenses. The Company expects to use the net proceeds from the Offerings for general working capital. A.G.P./Alliance Global Partners is acting as the sole placement agent for the Offerings. The Registered Offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-270994) previously filed with the U.S. Securities and Exchange Commission (the 'SEC'). A prospectus supplement describing the terms of the proposed Offering will be filed with the SEC and will be available on the SEC's website located at Electronic copies of the prospectus supplement may be obtained, when available, from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, or by telephone at (212) 624-2060, or by email at prospectus@ The private placement of the Common Warrants and the shares underlying the Common Warrants offered to the institutional investor will be made in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"). Accordingly, the securities issued in the concurrent private placements may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. About Offerpad Offerpad, dedicated to simplifying the process of buying and selling homes, is a publicly traded company committed to providing comprehensive solutions that remove the friction from real estate. Our advanced real estate platform offers a range of services, from consumer cash offers to B2B renovation solutions and industry partnership programs, all tailored to meet the unique needs of our clients. Since 2015, we've leveraged local expertise in residential real estate alongside proprietary technology to guide homeowners at every step. #OPAD_IR Forward-Looking Statements This release contains 'forward-looking statements' made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are typically preceded by words such as 'believes,' 'expects,' 'anticipates,' 'intends,' 'will,' 'may,' 'should,' or similar expressions. These forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct or that those goals will be achieved, and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, risks associated with market conditions and the satisfaction of customary closing conditions related to the proposed offering and uncertainties related to the size, timing, completion, and use of proceeds from the proposed offering. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the Company's business in general, please refer to the Company's prospectus supplement to be filed with the SEC, and the documents incorporated by reference therein, including the Company's Form 10-K for the year ended December 31, 2024 and Form 10-Q for the quarter ended March 31, 2025. All forward-looking statements are expressly qualified in their entirety by this cautionary notice. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this release. The Company has no obligation, and expressly disclaims any obligation, to update, revise or correct any of the forward-looking statements, whether as a result of new information, future events or otherwise.